Mr. Speaker, my question is for the Minister of Health.
The minister herself claims that everything is now being done to ensure the quality of blood products and the safety of the blood supply in Canada. But we learned that the Canadian Bureau of Biologics has yet to approve two factor IX products used to treat haemophilia B.
How can the minister justify that these products, which are purer and of higher quality than existing products, have not been approved by the Canadian Bureau of Biologics after more than two years?